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Summary
Staphylococcal enterotoxins (SEs) have been shown to bind to major histocompatibility complex
(MHC) class II proteins and stimulate T cells in a V(ispecific manner, and these V(3 specificities
for various SEs have been well documented in mice and humans. This study was undertaken
in order to examine the ability ofhuman class II molecules to present SEs to human and murine
T cell hybridomas . Using a panel of transfectants expressing individual HLA class II antigens,
we have shown that HLADR alleles differ in their ability to bind and present SEs . Since the
HLADR proteins share acommon ci chain, these results indicate that the polymorphic /3 chain
plays an important role in SE binding and presentation to T cells . In addition, we have shown
that human class II isotypes markedly differ in their ability to present SEs. The results of this
study should provide information on the region ofMHC class II molecules that interacts with
foreign, and perhaps self, superantigens .
T
cells usually recognize peptide fragments of antigen that
he in the antigen-binding pocket ofMHC (1-4) . The
combination ofmany variable elements of the TCR confers
upon the T cell bearing it specificity for peptide antigen and
MHC (5, 6) . Recently, however, a group of T cell stimula-
tory antigens have been described that differ in several respects
from the classically defined peptide antigens. T cell recogni-
tion of these antigens, termed superantigens (7), is dictated
predominantly by the V/3 element of the TCR, and the in-
teraction is not strictly dependent on theMHC class II al-
lele. Mls-1', Mls-2', Mls-3a, and a B cell-specific product are
examples of self-superantigens (8-11) that have been well
studied, yet the molecular nature of the self-superantigens
has remained elusive .
The Staphylococcal enterotoxins (SEs) 1 stimulate murine
and human T cells (12, 13), and appear to mimic self-
superantigens in their VO specificity (7, 14) . T cell stimula-
tion by SE requiresMHC class II molecules on an APC (7,
15), and several studies have shown specific binding of SE
toMHC class II (16-18) . These foreign superantigens do not
require proteolytic fragmentation for their activity (14-16),
'Abbreviations used in this paper : bio, biotin-labeled ; EXF, exfoliating
toxin; PE-Av, PE coupled to streptavidin ; RSV, Rous sarcoma virus ;
SE, Staphylococcal enterotoxin ; TSST, toxic shock syndrome toxin 1 .
and SEs are probably not presented by MHC in the same
manner as peptide antigens.
The studies in this paper were conducted to examine the
ability of different human class II proteins to bind SEs and
stimulate human and murine T cells. This analysis showed
that different human class II proteins did indeed differ in these
assays. The experiments revealed that the allele of the0chain
of HLA-DR was crucial in SE binding and stimulation of
T cells . These observations provide clues about the interac-
tions betweenMHC class II proteins, superantigens, and the
V(3 component of the TCR .
Materials and Methods
Cell Lines.
￿
The generation and characterization of the T cell
hybrids used in this study have been described elsewhere (7, 10,
19) . All of the T hybrids used in this paper express only a single
TCR, as they were generated by fusion ofT cells with an a- /3 -
variant of the BW 5147 thymoma (20) .
CH12 .1 is a murine B cell lymphoma that expresses I-Ati and
I-El", and has been used previously for toxin stimulation (7, 21) .
Raji is a human B lymphoma cell line that expresses HLA-DR3
and DRw10, HLA-DQwl and DQw2, and HLA-DP7 (22, 23).
Jurkat is a human T cell tumor line (24) .
Human MHC Class II Transfectants . Full-length cDNAs en-
coding a chains of class II HLA-DR alleles (DR1, DR2 Dw2,
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DPw2) were introduced into the eukaryotic expression vector
RSV3, as previously described (25) . Full-length cDNAs encoding
theDRa, -DQwltx, andDPw2a chains were introduced into the
eukaryotic expression vector RSV5 . The RSV5 expression vector
contains two expression units : the first one consists of the Esche-
richia coli guanine phosphoribosyl transferase gene encoding resis-
tance to mycophenolic acid, and the second one has the Rous sar-
coma virus (RSV) long terminal repeat driving the expression of
the class II cDNA (25) . Transfections into the adherent murine
fibroblastic line were carried out by the calcium phosphate precipi-
tation technique (26) . Briefly, DAP-3 cells were cotransfected with
2 lAg of each class II a chain in the RSV5 expression vector and
10 lAg of the isotype-matched class II # chains . Mycophenolic
acid-resistant cells were selected, and homogeneous populations
ofcells expressing comparable levels of class II alleles and isotypes
were obtained using a single cell cloning deposition system and
aseptic cell sorting on the FACstar plus (Becton Dickinson & Co.,
Mountain View, CA) flow cytometer. Levels of class II were as-
sessed by flow rytometry using an indirect fluorescence assay and
a mAb, SG465, that recognizes a monomorphic determinant ex-
pressed on all class II alleles and isotypes (27, 28) . Transfected cells
were maintained in culture in medium containing the selective agent .
Stimulation ofTCell Hybrids.
￿
T hybridoma cells, at 101/well,
were combined with 10s APCs and 1 Fig/ml SEs in 96-well plates
(7, 19) . IL2 production by the T cells was determined by the sur-
vival ofan 11,2-dependent cellline,HT2, measured visually orusing
3-[4,5-dimethylthiazol-2yll-2,5-diphenyltetrazolium bromide (MTT)
(Sigma Chemical Co ., St . Louis, MO) (29, 30) .
Toxins.
￿
The SEs used in this study were staphylococcal entero-
toxin A (SEA), staphylococcal enterotoxin B (SEB), staphylococcal
enterotoxin C1 (SEC1), staphylococcal enterotoxin C2 (SEC2),
staphylococcal enterotoxin C3 (SEC3), staphylococcal enterotoxin
D (SED), staphylococcal enterotoxin E (SEE), Toxic shock syn-
drome toxin 1 (TSST), and exfoliating toxin (ExF) . The SEs were
obtained from Toxin Technology (Madison, WI) . Lyophilized toxins
were dissolved in balanced salts solution, filter sterilized, and stored
at 4°C until use .
Staphylococcal toxins were biotinylated using a standard proce-
dure. Toxins were dissolved in 0 .1 M sodium bicarbonate buffer,
adjusted to a concentration of 1 mg/ml, and incubated with a 20-
fold molar excess of succinimidobiotin (Sigma Chemical Co .) dis-
solved in DMSO . The reaction was allowed to proceed at room
temperature for 2 h, and then the free biotin was removed by ex-
tensive dialysis against PBS.
Toxin Binding Analysis.
￿
The binding of toxins to APC was mea-
sured using a fluorescence assay as follows . 2 x 10 5 cells, in
staining buffer (PBS, 2% FCS, 0.08% sodium azide), were mixed
with different concentrations of biotin-labeled toxins (bio-SE) in
individual wells of 96-well microculture plates and incubated at
37°C for 45 min . The plates were washed four times with staining
buffer before addition of PE coupled to streptavidin (PE-Av ; Tago
Inc ., Burlingame, CA) and incubation on ice for 20 min . The cells
were washed four times with staining buffer before cytofluoro-
graphic analysis on an Epics C cell sorter (11) . Specific binding of
the bio-SE was demonstrated by the ability to completely inhibit
the fluorescence signal with the addition of 100-fold excess of un-
labeled toxin to the initial mixture of cells and bio-SE, and by the
lack of staining of nontransfected L cells. The fluorescence inten-
sity was calculated by subtraction of the anti-log of the fluores-
cence signal obtained by staining the cell line with PEAv only from
the anti-log of the value obtained with bio-SE + PE-Av .
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Murine T Cell Hybrids Respond to SEs Presented byHuman
Class II. Earlier reports have shown that individual SEs bind
to human or murine class II molecules, and that this com-
plex stimulates human or murine T cells, respectively, in a
toxin- and VO-specific manner (7, 14, 19, 31, 32) . T cells
bearing murine V#3, for example, are stimulated by almost
all the SEs bound to any murine class 11 molecule . T cells
bearing murineVfl, on the other hand, are stimulated only
by SEA + murine class II, andT cells bearing murine V(36
are not stimulated by any of the SEs bound to murine class
11 antigens .
In these studies, we wished to assess the ability of different
human class II molecules to bind and present SEs to T cells
bearing different VOs . A panel of murine L cell lines trans-
fected with different human class II molecules were therefore
tested for their ability to stimulate a human T cell tumor
line, Jurkat, in the presence of SEs . To supplement these ex-
periments, and for lack of a large collection of well charac-
terizedhumanT cell lines able to respond to transfected mu-
rine L cells, a battery of murineT cell hybridomas were also
used in the same assays .
Jurkat and a panel of murine T cell hybrids were tested
for their ability to produce 11,2 after stimulation by SEs with
murine or human APC. Some sample results are shown in
Table 1 . The human T cell line, Jurkat, responded to SEA,
SEB, SED, andSEE in the presence ofRaji cells . This pattern
was broader than expected, since we have previously shown
that normal T cells bearing human V08, the VO expressed
onJurkat, respond well only to SEE, and marginally to SED,
presented by normal human mononuclear cells (31) . There
are several possible reasons for the additional SE responses
seen with Jurkat in these experiments . The analysis of toxin
responses conducted with bulk human T cells (31) could not
distinguish between individual members of the V08 family,
and it is conceivable that differences might arise with the
study of Jurkat, a clonal T cell line that expresses human
Vf8.1 . These additional SE responses by Jurkat in this assay
may reflect the contributions of other variable elements of
the Jurkat TCR itself, or alternatively, Raji may be a more
efficient presenter of SEs than nontransformed human cells .
It seems likely that the alleles, isotypes, or relative densities
of class II proteins expressed by Raji played an important role,
since the response ofJurkat to toxins presented by cells bearing
onlyHLADRl was limited toSED andSEE. Jurkat responded
solely to SEE when the toxins were presented by the murine
class II-expressing APC, CH12.1 .
A T cell hybridoma bearing murine V/33, K25-49.16,
responded to SEA, SEB, SED, TSST, and ExF in the pres-
ence ofCH12.1 . This result was in close agreement with the
data obtained in experiments using bulk murineT cells, where
V(03-expressing T cells have been shown to respond to these
SEs, and additionally, SECT (19) . The use of human class
11--expressingAPC (Raji- or HLA-DRl-transfected cells) led
to broader toxin responses by K25-49.16, as evidenced by its
IL-2 production in response to SEC1 and SEE .
HLA-DR Allele Ability to Present Staphylococcal Enterotoxins Differs" jurkat is a human T cell line expressing V08 (h VS8) . K25-49.16 is a murine T hybridoma that expresses the V03 element (m VS3) .
KMLs-12.6 and KMLs-13.11 express the murine V06 element .
t CH12.1 is a mouse B cell lymphoma expressing I-Ak and I-Ed1k . Raji is a human B cell tumor bearing HLA-DR3, -DRw10, -DQwl,
-DQw2, -DP7 . DAP-DR1 is a mouse fibroblast that expresses human HLA-DRI.
S IL-2 production in response to SEE, TSST, and ExF was not measured in this experiment . In five other experiments, V06-bearing T cells
failed to produce any detectable amounts of IL-2 when these SEs were presented by these APC.
The most remarkable results shown in Table 1 concern the
responses ofT cell hybrids bearing murineV06 . In previous
studies, T cells bearing this Vo were not stimulated by any
of the SEs in the presence of murine presenting cells (7, 19),
a result confirmed here when CH12.1 was used as APC . In
contrast, five individual V06-bearingT hybrids (two of which
are shown in Table 1) responded to SEB, SECT, SEC2, SEC3,
and SED when the toxins were presented by human class
II-bearing APC.
Overall, therefore, the data in Table 1 show that SE reac-
tivities by different T cells can be demonstrated using this
approach, and considerable cross-species activity occurred . In
general, T cells showed a broader range of toxin responses
in the presence of human, rather than murine, class II . No
reactivities observed with murine class II-bearingAPC were
lost when human class II-expressing APC were used, and
additional SE reactivities were frequently seen with the latter .
These additional reactivities elicitedby APC bearing human
class II could be due to higher affinities of SE for thehuman
rather than murine MHC molecules, leading to increased
ligand concentrations and subsequent T cell responses. It
should be noted, however, that even though T cells bearing
a particular Vii responded to a broader range of SEs in the
presence of human class II, as opposed to murine class II,
VO specificity for the toxins was maintained, as summarized
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in Table 2, which includes data obtained withT cell hybrids
bearing a number of different murine Vos .
SEA Displays a Higher AffinityforHuman Class II Proteins
than for Murine Ia Antigens. A toxin binding assay, using
biotinylated SEA (bio-SEA), PL-Av, andcytofluorographic anal-
ysis, was developed in order to determine whether SEs differ
in their binding to human and murine class II molecules .
Fig . 1 shows that Bio-SEAboundmuch better to thehuman
B cell line Raji than to the mouse B cell line CH12.1 . The
relative affinity ofbio-SEA for the class II molecules expressed
on Raji was -100-fold higher than its affinity for the mu-
rine class II proteins expressed onCH12.1. This disparity could
not be due to differences in levels ofMHC ligands present
on the two B cell lines, since the level ofHLA-DR antigens
expressed on Raji was only twofold higher than the amount
of I-E molecules present on CH12.1(data not shown) . Similar
differences in thebinding ofbiotinylated SEB, SEC1, andSEE
to human and murine class II-bearing cells indicate that the
other SEs have higher affinities for humanMHC molecules
(data not shown), and that these binding differences may ac-
count for the enhanced SE responses observed with murine
T hybrids and APCs expressinghumanMHC class II antigens.
HumanHLA-D Isotypes Differ in theirAbility to Trigger Mu-
rine T Hybrid Toxin Responses . We wished to investigate
whether all the human class II isotypes could present SEs
Table 1 . Human and Murine T Cell Responses to SEs Presented by Either Mouse or Human Class II Molecules
T cell APC None SEA
IL-2
SEB
production
SEC1
in response to
SED
toxin :
SEE TSST ExF
U/m1
Jurkat* CH12.1t <10 <10 <10 <10 <10 320 <10 <10
(h V08) Raji <10 160 40 <10 >640 >640 <10 <10
DAP-DR1 <10 <10 <10 <10 >640 >640 <10 <10
K25-49.16 CH12.1 <10 >640 >640 <10 >640 <10 320 >640
(m V03) Raji <10 >640 >640 >640 640 >640 >640 >640
DAP-DR1 <10 >640 >640 >640 >640 >640 640 >646
KMLs-12.6 CH12.1 <10 <10 <10 <10 <10 NDS ND ND
(m V06) Raji <10 <10 <10 40 40 ND ND ND
DAP-DR1 <10 <10 320 >640 >640 ND ND ND
KMLs-13.11 CH12.1 <10 <10 <10 <10 <10 ND ND ND
(m V06) Raji <10 160 <10 320 40 ND ND ND
DAP-DR1 <10 20 80 320 40 ND ND NDTable 2.
￿
Changes in Toxin Reactivities of Murine T Cell
Hybrids as a Function of the Species Origin of the APCs
Class II Molecules
(ExF)
￿
TSST
Weak SE responses observed in the mouse are listed in parentheses .
equally effectively, since preferential binding by some SEs to
some isotypes has been reported (17, 33). Since the human
B cell lymphoma, Raji, expresses all three isotypes and was
thereforenot useful for these experiments, we used the L cell
transfectants expressing individual isotype molecules .
Bio-SEA (gM)
Figure 1.
￿
SEA shows a greater affinity for human MHC class Il
antigens than for murine class II molecules . The human B lymphoma
cell line, Raji, and the murine B cell lymphoma, CH12 .1, were tested
for binding of bio-SEA. The levels of bio-SEA binding are expressed
as fluorescence intensity, which was calculated as described in
Materials and Methods.
Theresults are shownin Table 3 . DifferentHLA isotypes
did indeed differ in their ability to present SEs. HLA-DR1
was the most efficient presenter, HLADQwl was inter-
mediate, and HLADPw2 was the least effective presenting
molecule . The V(01-expressing T hybrid, KSEA-1.8, for ex-
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The T cell designations are as described in Table I .
' The APC were transfected L cell fibroblasts expressing individual human class II isotypes .
t In other experiments, Jurkat failed to produce detectable levels of IL-2 in response to TSST or ExF presented by these APC.
Table 3. Human HLA-D Isotypes Differ in Their Ability to Present SEs to T Cells
IL-2 production in response to toxin :
T cell APC None SEA SEC1 SEE TSST ExF
U/ml
Jurkat' DAP-DR1" <10 20 10 >640 NDt ND
(h V08) DAP-DQwl <10 <10 <10 80 ND ND
DAP-DPw2 <10 <10 <10 160 ND ND
KSEA-1.8 DAP-DR1 <10 >640 10 >640 40 640
(m Vol) DAP-DQwl <10 160 <10 <10 <10 <10
DAP-DPw2 <10 <10 <10 <10 <10 <10
K25-59.6 DAP-DR1 <10 >640 80 80 320 >640
(m V03) DAP-DQwl <10 >640 <10 <10 <10 <10
DAP-DPw2 <10 320 <10 <10 <10 <10
KMLs-12 DAP-DR1 <10 <10 640 <10 <10 10
(m V06) DAP-DQwl <10 <10 >640 <10 <10 <10
DAP-DPw2 <10 <10 <10 <10 <10 <10
Murine
Vo
Toxin responses
with murine class II
Additional responses
with human class II
T
N c
d
1 SEA SEB, SEE, TSST, ExF
c
3 SEA, SEB, SED, SECT, SEC2, SEC3,
N
TSST, ExF SEE m
`o
6 None SEA, SEB, SECT,
SEC2, SEC3, SED
8.1 SEB, SED (SEC3) SECT, SEC2, SEC3,
ExF
8.2 SEB, SECT, SEC2, SEA, TSST, ExF
SEC3, SED (SEE)
8.3 SEB, SEC1, SED SEA, SEC2, SEC3,The T cell designations are described in Table 1. The APC were transfected L cell fibroblasts expressing HLA-DRI, HLA-DR2 Dw2, HLA-
DR4 (Dw4), HLA-DR6 (w52c), HLA-DR7, and HLA-DRw53, respectively. All of the T cells, with the exception of Jurkat, did not pro-
duce detectable levels of IL-2 (<10 Ulml) in response to APC alone.
See Table 1.
t The mAb SG465 recognizes an epitope common to HLA-DR, HLA-DQ, and HLA-DP (27, 28). Fluorescence staining was performed as
described in Materials and Methods, using biotin-labeled SG465, followed with PE-Av, and analyzed by cytofluorography. The mean channel
fluorescence values are listed here.
S In a separate experiment using biotin-labeled SG465 + PE-Av, the DAP-DR1 transfectant was shown to express approximately twofold
higher levels of HLA-DR than the HLA-DRw53 cell line.
ample, responded to SEA, SECT, SEE, and TSST with the
HLADRl transfectant, but only to SEA with HLA-DQwl
cells, and to no toxins presented by HLA-DPw2. In fact, there
were only two cases where the T cells used in this study
responded to SEs presented by HLA-DPw2. Jurkat produced
IIr2 in response to SEE, and murine V03-expressing T cells
responded to SEA with this class Il isotype. Similar dispari-
ties, either in termsofabsolute responses or quantitative differ-
ences in magnitudes of response, were observed with the other
T cells.
The differences in toxin stimulation seen with these human
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class II transfectants could not be attributed to the level of
surface expression of class II on the cells, since cytofluoro-
graphic analysis of these APCs with an antibody that recog-
nizes an epitope common to all three isotypes showed that
the HLA-DP transfectant expressed the highest level ofclass
II, and the HLADR and HLA-DQ transfectants expressed
nearly equivalent levels ofMHC molecules (data not shown).
These results indicated that the human class II isotypes
differed dramatically in their ability to present SEs. HLA-
DR1 was the most effective presenting molecule, whereas
HLA-DPw2 was the poorest presenter.
Table 4. Toxin-specific T Cell Responses Are Influenced by the HLA-DR Allele on the Presenting Cell
T cell Toxin DRl
IL-2
DR2
production in
DR4
response to SE +
DR6
APC:
DR7 DRw53
U/m1
Jurkat None <10 10 40 40 40 40
(h V08) SEA <10 20 40 80 40 40
SECT <10 20 40 40 40 40
SEE >640 >640 >640 7640 7640 40
TSST 20 80 40 40 40 40
KSEA-1.8 SEA >640 >640 >640 >640 >640 <10
(m Vol) SECT 40 <10 <10 <10 <10 <10
SEE >640 >640 >640 20 10 <10
TSST 40 <10 10 <10 <10 <10
K25-49.16 SEA >640 320 160 160 320 320
(m V03) SECT >640 <10 80 <10 <10 <10
SEE >640 160 320 160 320 <10
TSST 640 20 80 <10 <10 <10
KMLs-12.6 SEA <10 <10 <10 <10 <10 <10
(m V06) SECT >640 320 >640 80 40 >640
SEE ND` ND ND ND ND ND
TSST ND ND ND ND ND ND
K16-15.5 SEA 80 10 80 <10 <10 10
(m V08.2) SEC1 >640 640 >640 >640 >640 >640
SEE >640 80 640 80 160 <10
TSST <10 <10 <10 <10 <10 20
Mean channel fluorescence:
SG465 (ot-DR, DQ, DP)t NDS 184 119 150 138 158Toxin Responses Are Influenced by the HLA-DR Allele on the
APC. A large panel of L cell transfectants expressing different
HLADR alleles were examined for their ability to present
SEs to T cells bearing different Vos. The results obtained
with several of these transfectants are presented in Table 4.
The data in Table 4 indicate that the toxin reactivities of a
particular T cell are indeed affected by the HLA-DR allele
on the APC. For example, K25-49.16 (V03) responded to
SEC1 presented by the HLADR1- and HLADR4-expressing
APC, but not to the same SE presented by the HLADR2-,
HLADR6-, HLADR7-, and HLADRw53-expressing trans-
fectants. Similar results were obtained with the other T cells.
Overall, the differential ability ofcellsbearing the different
HLADR alleles to present toxins did not correlate with levels
of HLA-DR expressed on the APC (Table 4). The HLA-
DR4+ line, for example, bore the lowest level of HLA-DR
of these APC, yet it was a reasonably efficient SE presenter.
Most strikingly, the HLADRw53 transfectant expressed one
of the highest levels of HLA-DR, and yet it was the poorest
presenter. APC expressing this HLA-DR molecule failed to
present SEC1, SEE, and TSST to K25-49.16, and yielded
similar results with many other T hybrids. The V06-bearing
T hybrids were exceptional by virtue of their strong responses
to SECT presented by HLA-DRw53 (Table 4, and data not
shown). Interestingly, HLADRw53 was the only HLADR
molecule that failed to present a particular SE to any of the
T hybrids. None of the T cells responded to SEE with the
HLA-DRw53-bearing APC. K16-15.5, a V08.2-expressing
T hybrid, did not produce detectable amounts of IIr2 in re-
sponse to SEE and HLA-DRw53, though this hybrid did
respond to SEB and the HLADRw53 APC.
This marked difference in toxin presentation was tested
in more detail by measuring the dose response of K16-15 .5
c
"V
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Figure 2.
￿
Dose response of a murine V08.2-expressing T cell hy-
bridoma, K16-15 .5, to SEB and SEE presented by transfected L cell
fibroblasts expressing HLA-DRI or HLA-DRw53. IL2 production
was assessed by uptake of the vital dye MTT (30) by the I1,2
dependent cell line HT2. MTT uptake was measured with a Biotek
Microplate Autoreader E1r311 (Biotek Instruments, Inc., Winooski,
VT) at a wavelength of 570 nm, and the values given have been ob-
tained by calibration with an 11,2 standard. Values of <10 U/ml were
not significantly above background.
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to SEB and SEE with the HLADR1 and HLADRw53 trans-
fectants (Fig. 2). The SEB response of K16-15.5 was nearly
equivalent when HLADR1 or HLA-DRw53 were used as
presenting molecules. The two HLA-DR antigens dramati-
callydiffered, however, in their ability to present SEE to K16-
15.5. No detectable IIr2 was produced with the HLADRw53
APC, while the titration of SEE with the HLADR1 APC
gave high levels of 11,2.
This demonstration that HLA-DR alleles differ in their
ability to stimulate T cellsagainst SEs implies that the HLA-
DR /3 chain must be a determining factor, since HLA-DR
molecules all share the same ci chain. A role for the a chain,
however, could not be excluded by these findings.
Failure of HLA-DRw53 to Present SEE to T Cells Is Due
to PoorBinding ofSEE to this Class IIMolecule. The apparent
failure of HLADRw53 to present SEE to the panel ofT cells
could be the result of lack of toxin binding to this MHC
molecule, or could be due to SEE binding to HLADRw53
in a manner that does not allow T cell stimulation. The toxin
binding assay was used to distinguish between these possibili-
ties. The binding ofbio-SEA and bio-SEE to the HLADR1
and HLADRw53 transfectants is shown in Fig. 3 . The toxins
showed high levels of binding to the HLADR1-expressing
cell line, but very low levels ofbinding ofSEA and SEE were
seen with the HLADRw53 transfectant. The binding of SEA
and SEE to HLADRw53 was greater than two orders of
magnitude less than the binding of these SEs to HLADR1.
This dramatic reduction of bio-SEE binding to HLADRw53
explained why this HLADR molecule failed to stimulate
with SEE, and this result showed that the HLA-DR a chain
determines toxin binding. Interestingly, the binding of bio-
SEA to the HLADRw53 transfectant was also greatly di-
minished compared with the binding seen with HLA-DR1.
Bio-SE (~A)
Figure 3.
￿
The HLA-DRw53 molecule binds SEA and SEE poorly.
Transfectants expressing HLADR1 or HLA-DRw53 were tested for
binding of bio-SEA and bio-SEE. The levels of bio-SE binding to the
transfectants are expressed as fluorescence intensity, which was calcu-
lated as described in Materials and Methods.
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7This finding may explain why many T cells used in these
studies failed to respond to SEA with this transfectant, and
why only a few hybrids could respond to this SE in the con-
text of HLA-DRw53 (Table 4, and data not shown) . Pos-
sibly, the presence of a high affinity TCR could stabilize an
apparentlyweak interaction betweenSEA andHLADRw53
molecules, and the formation of this trimolecular complex
would lead to 11,2 secretion by the T hybrid .
Discussion
The experiments presented in this manuscript demonstrate
that HLA-DR alleles differentially present SEs to T hybrid-
omas . These results were unexpected, since it had been pre-
viously thought that the class II molecule acts as an almost
generic platform for SE interactions with V(3 elements, and
this appeared to implicate the nonpolymorphic u chain of
MHC class II molecules in toxin stimulation. The results
of a study on the binding of SEB and TSST to a collection
of transfectants expressing HLA class II antigens led the
authors to conclude that HLA polymorphisms did not affect
binding of these toxins (18) . However, the data obtained in
this study showed that several alleles ofHLADR differed
in their ability to bind and present several toxins . Since all
HLADR molecules share a common u chain, these results
mapped an important site for MHC-SE, and TCR-MHC-
SE, interactions to the 0 chain of HLA-DR . The finding
that class II alleles differentially support SE stimulation of
T cells may suggest that class II allelism influences an indi-
vidual's susceptibility to SE intoxications.
The poorest SE presenter among theHLADR alleles tested
wasHLADRw53 . This was shown to be due to poor binding
ofSEA and SEE to this HLA-DR molecule . Comparison of
HLA-DR sequences shows that HLADRw53 is the least
related to the consensus sequence forHLADR (34), and it
is most likely that these differences in conserved regions of
HLA-DR play a role in toxin binding toMHC . This infor-
mation should provide clues for the region of theMHC mol-
ecule that interacts with SE .
The application ofa panel ofL cells transfected with different
isotypes ofhuman class II allowed us to compare the relative
abilities of HLADR, HLA-DQ, and HLADP to present
toxins to T hybrids . The hierarchy for supporting SE stimu-
lation (HLA-DR > HLA-DQ > HLA-DP) was similar to
that seen with murine isotypes (7, 14), where the structural
homologue of HLA-DR, I-E, supported SE responses more
efficiently than the HLA-DQ homologue, I-A . In general,
this hierarchy of SE stimulation for the human class II iso-
types supported the observations made by other workers of
SE binding to the Raji B cell line (33) . Interestingly, Herr-
mann et al . (33) were unable to detect ExF binding to Raji,
while the results presented here (Table 3) indicate that ExF
could be presented by HLA-DR1, but not by HLA-DQw1
or HLA-DPw2 . It is perhaps more than coincidental that
HLADR and I-E are the most efficient presentation mole-
cules for SE . It has been shown that I-E serves as a ligand
for self-superantigens, and plays a pivotal role in thymic se-
lection in the mouse (11) . One might speculate that I-E, and
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HLA-DR have maintained common structural motifs that
are recognized by SEs and self-superantigens, a species that
has yet to be defined in humans.
These experiments have shown that murine T cells were
more likely to respond to a given SE presented by human
class II, than the same toxin presented by murine class II .
Thus, in every case where a T cell hybrid responded to an
SE + murine class II, it would respond to the same SE +
human class II . Additional responses were seen, however, when
human class II was used to present SEs to murine T cell
hybrids . Most strikingly, T cell hybrids bearing V06, which
do not respond to any SE presented by murine class II, did
respond to some ofthe SEs, particularly SEC1, presented by
human class II molecules .
It is possible that the murine responses to toxins presented
by human class II were broader than when murine class II
composed part of the ligand, becauseTCRs have higher affini-
ties for class II antigens of other species, since these T cells
have not been selected for tolerance to such xenoantigens .
If this increased affinity ofTCRs for xenogeneicMHC were
the pivotal requirement for broader SE reactivities, one would
predict that the human T cells would respond to more SEs
presented by murine APC than by human APC. A broader
reactivity pattern, however, was not observed with one human
T cell line, Jurkat, and xenogeneicMHC . Another explana-
tion is that SE have higher affinities forhuman than for mu-
rine class II, and these differences are manifested by triggering
wider T cell responses . The comparison of bio-SEA binding
to murine and human B cell lines demonstrated that SEA
displays a higher affinity for human class II molecules (Fig.
1) . The additional toxin responses, therefore, would simply
be due to enhanced toxin binding to HLADR, and there-
fore, an increased concentration ofligand. It should be noted,
however, that the SE that has the highest affinity forMHC
class II, SEA (16, 35, A . Herman, personal observations),
is not the toxin that most often stimulates murine T cells
when it was presented by HLA-DR . Thiswould imply that
SE specificity still resides, in part, at the level of the TCR
and V/a In this context, it is also worth noting that Staphylo-
coccus aureus, the organism that secretes these SEs, is a human
pathogen, and these SEs may therefore have evolved to in-
teract with human rather than murine MHC proteins .
Sometimes, the ability of a particular SE to bind to a specific
class II protein did not correlate well with the ability of the
SE + MHC complex to stimulateT cells (18, and this study) .
Although SEA and SEE both bind very poorly to HLA
DRw53, the former toxin, in association withHLADRw53,
could stimulate someT cells while the latter could not . This
finding probably reflects the fact that T cell stimulation in
these experiments is the result of the formation of a tri-
molecular complex ofTCR + SE + MHC class II . ATCR
with very high affinity for toxin + MHC may be able to
stabilize aweak interaction between a SE and anMHC mol-
ecule, and thus, T cells bearing particular V(3s may be able
to respond to a particular SE + MHC combination, even
though the latter interaction cannot easily be demonstrated
by binding.
The results obtained from this studymay help to elucidatethemode in whichforeign superantigens interact withMHC
class II molecules. The SEs have been studied intensively be-
cause they share several important properties with self-
superantigens, whose structures are, as yet, undefined. The
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